Drug conjugates-an emerging approach to treat breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug conjugates-an emerging approach to treat breast cancer

Published:2018-07 Issue:4 Volume:6 Page:e00417
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Hasan Mahmud¹^ORCID,Leak Rehana K.¹^ORCID,Stratford Robert E.²^ORCID,Zlotos Darius P.³^ORCID,Witt-Enderby Paula A.¹⁴^ORCID

Affiliation:

1. Division of Pharmaceutical, Administrative, and Social Sciences; Duquesne University; Pittsburgh PA USA

2. Indiana University School of Medicine; Indianapolis IN USA

3. Department of Pharmaceutical Chemistry; The German University in Cairo; New Cairo City; Cairo Egypt

4. University of Pittsburgh Cancer Institute; University of Pittsburgh; Pittsburgh PA USA

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/prp2.417/fullpdf

Reference124 articles.

1. Combinatorial drug therapy for cancer in the post-genomic era;Al-Lazikani;Nat Biotechnol,2012

2. Preclinical studies of targeted [alpha] therapy for breast cancer using 213Bi-labelled-plasminogen activator inhibitor type 2;Allen;Br J Cancer,2003

3. The promise of retinoids to fight against cancer;Altucci;Nat Rev Cancer,2001

4. Nanosized tamoxifen-porphyrin-glucose [TPG] conjugate: Novel selective anti-breast-cancer agent, synthesis and in vitro evaluations;Amanlou;Med Chem,2013

5. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model;Arap;Science,1998

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a Supermolecular Radionuclide-Drug Conjugate System for Integrated Radiotheranostics for Non-small Cell Lung Cancer;Journal of Medicinal Chemistry;2024-06-19

2. Designing a novel drug–drug conjugate as a prodrug for breast cancer therapy: in silico insights;Molecular Diversity;2024-06-04

3. Drug–drug conjugates of MEK and Akt inhibitors for RAS-mutant cancers;Bioorganic & Medicinal Chemistry;2024-03

4. Design and synthesis of dual BRD4/Src inhibitors for treatment of triple-negative breast cancer;European Journal of Medicinal Chemistry;2024-01

5. Urolithin A conjugation with NSAIDs inhibits its glucuronidation and maintains improvement of Caco-2 monolayers' barrier function;Biomedicine & Pharmacotherapy;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3